And based on DAS28-CRP, RA patients were divided into 102 (48%) of remission, 21 (10%) of low disease activity, 57 (27%) of moderate disease activity, 30 (14%) of high disease activity, respectively. This evidence concerns the gene CRP and rheumatoid arthritis.